Neurogene Inc. Foreign Currency Transaction Gain (Loss), Unrealized
Neurogene Inc. (NGNE) reported Foreign Currency Transaction Gain (Loss), Unrealized of $0 for the 6-month period ending 2021-06-30, per its 10-Q filed 2021-08-05.
Discontinued › Cash Flow › Operating Activities
us-gaap:ForeignCurrencyTransactionGainLossUnrealized · last filed 2021-08-05
- Neurogene Inc. foreign currency transaction gain (loss), unrealized for the quarter ending 2021-06-30 was $0.00, a 100.00% decline year-over-year.
- Neurogene Inc. foreign currency transaction gain (loss), unrealized for the quarter ending 2021-03-31 was $0.00, a 100.00% decline year-over-year.
- Neurogene Inc. foreign currency transaction gain (loss), unrealized for the quarter ending 2020-06-30 was $7.00K.
- Neurogene Inc. foreign currency transaction gain (loss), unrealized for the quarter ending 2020-03-31 was $14.00K.
- Neurogene Inc. foreign currency transaction gain (loss), unrealized for fiscal 2020 was $0.00.
- Neurogene Inc. foreign currency transaction gain (loss), unrealized for fiscal 2019 was -$70.00K.
- Neurogene Inc. foreign currency transaction gain (loss), unrealized for fiscal 2014 was -$107.75K.
| Period end | Foreign Currency Transaction Gain (Loss), Unrealized 3 month | Foreign Currency Transaction Gain (Loss), Unrealized 3 month as first filed | Foreign Currency Transaction Gain (Loss), Unrealized 6 month | Foreign Currency Transaction Gain (Loss), Unrealized 6 month as first filed | Foreign Currency Transaction Gain (Loss), Unrealized 9 month | Foreign Currency Transaction Gain (Loss), Unrealized 9 month as first filed | Foreign Currency Transaction Gain (Loss), Unrealized 12 month | Foreign Currency Transaction Gain (Loss), Unrealized 123 month |
|---|---|---|---|---|---|---|---|---|
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $0.00 10-Q · filed 2021-08-05 | ||||||
| 2021-03-31 | $0.00 10-Q · filed 2021-05-12 | |||||||
| 2020-12-31 | $0.00 10-K · filed 2021-03-25 | |||||||
| 2020-06-30 | $7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $21.00K 10-Q · filed 2021-08-05 | -$29.00K derived: sum of 3 quarters · filed 2021-08-05 | -$28.00K derived: sum of 4 quarters · filed 2021-08-05 | ||||
| 2020-03-31 | $14.00K 10-Q · filed 2021-05-12 | -$36.00K derived: sum of 2 quarters · filed 2021-05-12 | -$35.00K derived: sum of 3 quarters · filed 2021-05-12 | |||||
| 2019-12-31 | -$50.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | -$49.00K derived: sum of 2 quarters · filed 2021-03-25 | -$70.00K 10-K · filed 2021-03-25 | |||||
| 2019-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$20.00K 10-Q · filed 2020-11-09 | ||||||
| 2019-06-30 | -$21.00K 10-Q · filed 2020-08-12 | |||||||
| 2015-09-30 | -$13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | -$26.00K derived: sum of 2 quarters · filed 2015-11-10 | -$39.00K 10-Q · filed 2015-11-10 | $71.25K derived: sum of 4 quarters · filed 2015-11-10 | ||||
| 2015-06-30 | -$13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | -$26.00K 10-Q · filed 2015-08-06 | $84.25K derived: sum of 3 quarters · filed 2015-08-06 | $62.25K derived: sum of 4 quarters · filed 2015-11-10 | ||||
| 2015-03-31 | -$13.00K 10-Q · filed 2015-05-12 | $97.25K derived: sum of 2 quarters · filed 2015-05-12 | $75.25K derived: sum of 3 quarters · filed 2015-11-10 | $76.22K derived: sum of 4 quarters · filed 2015-11-10 | ||||
| 2014-12-31 | $110.25K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $88.25K derived: sum of 2 quarters · filed 2015-11-10 | $89.22K derived: sum of 3 quarters · filed 2015-11-10 | -$107.75K 10-K · filed 2015-03-16 | ||||
| 2014-09-30 | -$22.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | -$21.03K derived: sum of 2 quarters · filed 2015-11-10 | -$218.00K 10-Q · filed 2015-11-10 | -$107.75K 10-Q · filed 2014-11-04 | ||||
| 2014-06-30 | $972.00 10-Q · filed 2014-08-11 | -$196.00K 10-Q · filed 2015-08-06 | -$105.53K 10-Q · filed 2014-08-11 | |||||
| 2014-03-31 | -$125.00K 10-Q · filed 2015-05-12 | -$106.50K 10-Q · filed 2014-05-13 | -$106.50K 10-Q · filed 2014-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |